Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New upgrade:   Journal your trades with more detail

Read How
Market News Market Pulse Stocks News ETF News Crypto News

Geron Corporation

Contributing Author

Recent Articles by Geron Corporation

Aug-18
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire
Aug-05
Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights GERN +21.64% GlobeNewswire
Jul-22
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire
Jul-22
Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026 GERN GlobeNewswire
Jul-14
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire
Jul-13
Geron Announces Appointment of Chinmaya Rath as Chief Business Officer GERN -5.33% GlobeNewswire
Jun-18
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN GERN +6.35% GlobeNewswire
Jun-01
Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference GERN GlobeNewswire
May-18
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire
May-12
First Real-World Evidence Study of RYTELO (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 GERN GlobeNewswire
May-06
Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights GERN GlobeNewswire
May-05
Geron Plans to Present at Upcoming Investor Conferences GERN +5.10% GlobeNewswire
Apr-22
Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026 GERN GlobeNewswire
Apr-20
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN -7.14% GlobeNewswire
Apr-14
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire
Apr-13
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary GERN GlobeNewswire
Apr-06
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference GERN +5.42% GlobeNewswire
Mar-26
Geron Announces Appointment of New Members to its Board of Directors GERN GlobeNewswire
Mar-18
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire
Feb-25
Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights GERN -11.79% GlobeNewswire
Feb-23
Geron Plans to Present at Upcoming Investor Conferences GERN -5.85% GlobeNewswire
Feb-18
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN +7.78% GlobeNewswire
Feb-11
Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 GERN GlobeNewswire
Jan-12
Geron Corporation Provides 2026 Financial Guidance GERN +6.72% GlobeNewswire
Dec-18
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire
Dec-11
Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation GERN +8.59% GlobeNewswire
Dec-08
Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO (Imetelstat) in Lower-Risk MDS GERN GlobeNewswire
Oct-13
Geron Corporation Announces Executive Leadership Transitions and Appointments GERN GlobeNewswire
Sep-18
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)